13F
中

AVBP ARRIVENT BIOPHARMA INC

2026Q1 · CUSIP 04272N102 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
138
Δ holders QoQ
+16
Breadth percentile
Top 19%
Whale holders
73
Δ whales
+12
Inst. holding value
$968M
New positions
36
Closed positions
20
Price momentum (1Q)
+18.7%
Put / Call
3/4

Breadth history (34 quarters)

2024Q2: Δ+1 · h=55 2024Q3: Δ+14 · h=69 2024Q4: Δ+13 · h=82 2025Q1: Δ+2 · h=84 2025Q2: Δ+16 · h=100 2025Q3: Δ+5 · h=105 2025Q4: Δ+17 · h=122 2026Q1: Δ+16 · h=138 2024Q2: holders=55 2024Q3: holders=69 2024Q4: holders=82 2025Q1: holders=84 2025Q2: holders=100 2025Q3: holders=105 2025Q4: holders=122 2026Q1: holders=138 -17 -8.5 +0 +8.5 +17 4997145 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 19% — —
2025Q2 Top 19% +7.5% +20.8%

Options Sentiment

Put holders
3
QoQ: +3
Call holders
4
QoQ: +3

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-3.38
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.70 2024-06-30: EPS -0.65 2024-09-30: EPS -0.61 2024-12-31: EPS -0.60 2025-03-31: EPS -1.90 2025-06-30: EPS -0.90 2025-09-30: EPS -0.83 2025-12-31: EPS -0.69 2026-03-31: EPS -0.96 -2.09 -1.04 0.00 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)